heberon

A MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF HEBER ON (INTERFERON ALFA-2b) IN COMBINATION WITH RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C IN IRAN

Journal: Medical Journal of Islamic Republic of Iran 2005

A. SHARIFI, A. GHAVIDEL, F. MANSOURGHANAEI, H. FOROOTAN, H. MIRMOMEN, H. VOSOGHINIA, H. GHOFRANI, M. AMIRIAN, M. AZMI, M. FARAHVASH, M. NASIRI, M. TALEBI, M. ZAHEDI, N. DARYANI, SH. MIRMOMEN,

ABSTRACT Background: Combination therapy with interferon and ribavirin is the most effective treatment for chronic hepatitis C today. The aim of this study was to evaluate the efficacy and safety of thrice-weekly Heberon (interferon alfa-2b) in combination with ribavirin as first -line treatment of chronic hepatitis C. Methods: A total of97 treatment-naive patients received Heberon three milli...

متن کامل

safety and efficacy of interferon alfa for the treatment of chronic hepatitis c infected subjects with transfusion dependent thalassemia in iran

Journal: :medical journal of islamic republic of iran 0

s mirmomen from the digestive disease research unit of imam khomeini hospital, tehran university of medical sciences, tehran, i.r. iran. h ghofrani h forootan pishbuary n ebrahimi daryani m jafar farahvash ra sharifian

up to 30% of iranian adult multi-transfused thalassemic patients are infected with hepatitis c virus (hcv) which can intensify the progression of liver disease caused by iron overload in this group of patients. our aim was to assess the biochemical and virological response of interferon alfa (inf-α) and its safety in thalassemic patients with chronic hcv infection. this trial was a single cente...

متن کامل

the efficacy and sa fety of interferon alfa for the treatment of chronic hepatitis b infected subjects in iran

Journal: :medical journal of islamic republic of iran 0

h forootan pishbuary from the digestive disease research unit of imam khomeini hospital, tehran university of medical sciences, tehran, i.r. iran. s mirmomen from the digestive disease research unit of imam khomeini hospital, tehran university of medical sciences, tehran, i.r. iran. s alamdary from the digestive disease research unit of imam khomeini hospital, tehran university of medical sciences, tehran, i.r. iran. h ghofrani from the digestive disease research unit of imam khomeini hospital, tehran university of medical sciences, tehran, i.r. iran. mj farahvash from the digestive disease research unit of imam khomeini hospital, tehran university of medical sciences, tehran, i.r. iran. m y ossefi mashhoor from the digestive disease research unit of imam khomeini hospital, tehran university of medical sciences, tehran, i.r. iran.

this preliminary study was designed to evaluate the effects of heberon alfa for the treatment of chronic hepatitis b infected subjects in iran. a single center, open label, single treatment prospective study of interferon alfa (heberon alfa), 5 million units every other day for a period of 4 months, was performed between 1996 to 1998. a total number of 30 patients with histologically documented...

متن کامل

a multicenter study to evaluate the safety and efficacy of heber on (interferon alfa-2b) in combination with ribavirin for the treatment of chronic hepatitis c in iran

Journal: :medical journal of islamic republic of iran 0

h. forootan digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran. a. sharifi digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran. sh. mirmomen digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran. n. daryani digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran. h. ghofrani digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran. m. farahvash digestive research centel; tehran university of medical sciences, imam khomeini hospital, tehran.

abstract background: combination therapy with interferon and ribavirin is the most effective treatment for chronic hepatitis c today. the aim of this study was to evaluate the efficacy and safety of thrice-weekly heberon (interferon alfa-2b) in combination with ribavirin as first -line treatment of chronic hepatitis c. methods: a total of97 treatment-naive patients received heberon three millio...

متن کامل

THE EFFICACY AND SA FETY OF INTERFERON ALFA FOR THE TREATMENT OF CHRONIC HEPATITIS B INFECTED SUBJECTS IN IRAN

Journal: Medical Journal of Islamic Republic of Iran 2002

F GHANAIE, H FOROOTAN PISHBUARY, H GHOFRANI, M Y OSSEFI MASHHOOR, MJ FARAHVASH, S ALAMDARY, S MIRMOMEN,

This preliminary study was designed to evaluate the effects of Heberon Alfa for the treatment of chronic hepatitis B infected subjects in Iran. A single center, open label, single treatment prospective study of Interferon Alfa (Heberon Alfa), 5 million units every other day for a period of 4 months, was performed between 1996 to 1998. A total number of 30 patients with histologically docume...

متن کامل

SAFETY AND EFFICACY OF INTERFERON ALFA FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTED SUBJECTS WITH TRANSFUSION DEPENDENT THALASSEMIA IN IRAN

Journal: Medical Journal of Islamic Republic of Iran 2003

F AZMODEH, H FOROOTAN PISHBUARY, H GHOFRANI, M JAFAR FARAHVASH, N EBRAHIMI DARYANI, R MALEKZADEH, RA SHARIFIAN, S MIRMOMEN,

Up to 30% of Iranian adult multi-transfused thalassemic patients are infected with hepatitis C virus (HCV) which can intensify the progression of liver disease caused by iron overload in this group of patients. Our aim was to assess the biochemical and virological response of interferon alfa (INF-α) and its safety in thalassemic patients with chronic HCV infection. This trial was a single c...

متن کامل